Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Camilla Molich Hoff. (2012) Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Acta Oncologica 51:4, pages 419-432.
Read now
Read now
Krystyna Serkies, Andrzej Badzio & Jacek Jassem. (2006) Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy. Acta Oncologica 45:6, pages 695-701.
Read now
Read now
Kazimierz Karolewski, Stanislaw Korzeniowski, Andrzej Sokolowski, Krzysztof Urbanski & Zbigniew Kojs. (1999) Prognostic Significance of Pretherapeutic and Therapeutic Factors in Patients with Advanced Cancer of the Uterine Cervix Treated with Radical Radiotherapy Alone. Acta Oncologica 38:4, pages 461-468.
Read now
Read now
Articles from other publishers (37)
Amrendra Kumar, Lavanya Gurram, Pushpa Naga Ch, Prashant Nayak, Gargee Mulye, Supriya Chopra, Reena Engineer, Shyam Kishore Shrivastava, Sudeep Gupta, Jaya Ghosh, Seema Gulia, Jai Prakash Agarwal & Umesh Mahantshetty. (2024) Correlation of Hematological Parameters With Clinical Outcomes in Cervical Cancer Patients Treated With Radical Radio(chemo)therapy: A Retrospective Study. International Journal of Radiation Oncology*Biology*Physics 118:1, pages 182-191.
Crossref
Crossref
Christine Gennigens, Marjolein De Cuypere, Laurence Seidel, Johanne Hermesse, Annelore Barbeaux, Frédéric Forget, Adelin Albert, Guy Jerusalem & Frédéric Kridelka. (2020) Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy. Cancer Medicine 9:22, pages 8432-8443.
Crossref
Crossref
Gustavo Arruda Viani, Fred Muller dos Santos & Juliana Fernandes Pavoni. (2020) Significant impact on the oncologic outcomes with intensity modulated radiotherapy and conformational radiotherapy over conventional radiotherapy in cervix cancer patients treated with radiotherapy. Reports of Practical Oncology & Radiotherapy 25:4, pages 678-683.
Crossref
Crossref
Sybren L.N. Maas, Kaspar Draaisma, Tom J. Snijders, Joeky T. Senders, Sharon Berendsen, Tatjana Seute, Raymond M. Schiffelers, Wouter W. van Solinge, Maarten J. Ten Berg, Pierre A. Robe & Marike L.D. Broekman. (2019) Routine Blood Tests Do Not Predict Survival in Patients with Glioblastoma—Multivariable Analysis of 497 Patients. World Neurosurgery 126, pages e1081-e1091.
Crossref
Crossref
Paulina Cybulska, Cheryl Goss, William P. Tew, Rekha Parameswaran & Yukio Sonoda. (2017) Indications for and complications of transfusion and the management of gynecologic malignancies. Gynecologic Oncology 146:2, pages 416-426.
Crossref
Crossref
Maroie Barkati, Israël Fortin, Linda Mileshkin, David Bernshaw, Jean-François Carrier & Kailash Narayan. (2013) Hemoglobin Level in Cervical Cancer. International Journal of Gynecological Cancer 23:4, pages 724-729.
Crossref
Crossref
Giampiero Ausili Céfaro, Domenico Genovesi, Annamaria Vinciguerra, Marianna Trignani, Maria Taraborrelli, Antonietta Augurio, Roberto Buonaguidi, Renato J. Galzio & Marta Di Nicola. (2011) Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomidePrognostische Bedeutung des Hämoglobinspiegels und anderer allgemeiner Prognosefaktoren bei Patienten mit High-Grade Gliomen, die mit postoperativer Radiotherapie und Temozolomid-basierter sequentieller Radiotherapie behandelt wurden. 10-Jahres-Ergebnisse einer einzelnen Einrichtung. Strahlentherapie und Onkologie 187:12, pages 778-783.
Crossref
Crossref
Camilla Molich Hoff, Hanne Sand Hansen, Marie Overgaard, Cai Grau, Jørgen Johansen, Jens Bentzen & Jens Overgaard. (2011) The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy – Results from the randomized DAHANCA 5 study. Radiotherapy and Oncology 98:1, pages 28-33.
Crossref
Crossref
Matthew S. McKinney & Jeffrey Crawford. 2011. Practical Geriatric Oncology. Practical Geriatric Oncology
338
350
.
H.-G. STRAUSS, G. HAENSGEN, J. DUNST, C. R.W. HAYWARD, H.-U. BURGER, A. SCHERHAG & H. KOELBL. (2008) Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer. International Journal of Gynecologic Cancer 18:3, pages 515-524.
Crossref
Crossref
Takashi Kawanaka, Akiko Kubo, Hitoshi Ikushima, Toshiaki Sano, Yoshihiro Takegawa & Hiromu Nishitani. (2008) Prognostic significance of HIF-2.ALPHA. expression on tumor infiltrating macrophages in patients with uterine cervical cancer undergoing radiotherapy. The Journal of Medical Investigation 55:1,2, pages 78-86.
Crossref
Crossref
Jürgen Dunst & M. Molls. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
249
263
.
A. Garcia-Arias, L. Cetina, M. Candelaria, E. Robles & A. Dueñas-González. (2007) The prognostic significance of leukocytosis in cervical cancer. International Journal of Gynecologic Cancer 17:2, pages 465-470.
Crossref
Crossref
K.-L. Zhao, G. Liu, G.-L. Jiang, Y. Wang, L.-J. Zhong, Y. Wang, W.-Q. Yao, X.-M. Guo, G.-D. Wu, L.-X. Zhu & X.-H. Shi. (2006) Association of Haemoglobin Level with Morbidity and Mortality of Patients with Locally Advanced Oesophageal Carcinoma Undergoing Radiotherapy — A Secondary Analysis of Three Consecutive Clinical Phase III Trials. Clinical Oncology 18:8, pages 621-627.
Crossref
Crossref
Francisco José Andreu-Martínez & Julia M. Martínez-Mateu. (2005) Hypoxia and anaemia in patients with cancer of the uterine cervix. Clinical and Translational Oncology 7:8, pages 323-331.
Crossref
Crossref
C. Marchal, L. Rangeard & C. Brunaud. (2005) Impact de l'anémie sur les traitements des cancers du col utérin. Cancer/Radiothérapie 9:2, pages 87-95.
Crossref
Crossref
Shannah L. Murland. (2005) Tumour Oxygenation: The Importance of Hypoxia, Anemia, and Angiogenesis in Radiation Therapy. Canadian Journal of Medical Radiation Technology 36:1, pages 21-33.
Crossref
Crossref
Kenneth Hu & Louis B. Harrison. (2005) Impact of anemia in patients with head and neck cancer treated with radiation therapy. Current Treatment Options in Oncology 6:1, pages 31-45.
Crossref
Crossref
Daniel T. T. Chua, Jonathan S. T. Sham & Damon T. K. Choy. (2004) Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone. Cancer 101:2, pages 307-316.
Crossref
Crossref
Praca habilitacyjna & Andrzej Roszak. (2004) Badania nad skutecznością radiochemioterapii chorych na zaawansowanego raka szyjki macicy. Reports of Practical Oncology & Radiotherapy 9, pages S131-S199.
Crossref
Crossref
Juergen Dunst, Thomas Kuhnt, Hans G Strauss, Ulf Krause, Tanja Pelz, Heinz Koelbl & Gabriele Haensgen. (2003) Anemia in cervical cancers: Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. International Journal of Radiation Oncology*Biology*Physics 56:3, pages 778-787.
Crossref
Crossref
Philipp Burri, Valentin Djonov, Daniel M Aebersold, Katja Lindel, Ueli Studer, Hans J Altermatt, Luca Mazzucchelli, Richard H Greiner & G.ünther Gruber. (2003) Significant correlation of hypoxia-inducible factor-1α with treatment outcome in cervical cancer treated with radical radiotherapy. International Journal of Radiation Oncology*Biology*Physics 56:2, pages 494-501.
Crossref
Crossref
Bradly G. Wouters, Marianne Koritzinsky, Roland K. Chiu, Jan Theys, Jeroen Buijsen & Philippe Lambin. (2003) Modulation of cell death in the tumor microenvironment. Seminars in Radiation Oncology 13:1, pages 31-41.
Crossref
Crossref
Louis B. Harrison, Manjeet Chadha, Richard J. Hill, Kenneth Hu & Daniel Shasha. (2002) Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes. The Oncologist 7:6, pages 492-508.
Crossref
Crossref
Karin S Kapp, Johann Poschauko, Edith Geyer, Andrea Berghold, Astrid C Oechs, Edgar Petru, Manfred Lahousen & Daniel S Kapp. (2002) Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy. International Journal of Radiation Oncology*Biology*Physics 54:1, pages 58-66.
Crossref
Crossref
B.G Wouters, S.A Weppler, M Koritzinsky, W Landuyt, S Nuyts, J Theys, R.K Chiu & P Lambin. (2002) Hypoxia as a target for combined modality treatments. European Journal of Cancer 38:2, pages 240-257.
Crossref
Crossref
Jürgen Dunst & M. Molls. 2002. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
101
115
.
M. R. Nowrousian. 2002. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
369
390
.
Horst J. Feldmann. (2001) Oxygenation of human tumors—implications for combined therapy. Lung Cancer 33, pages S77-S83.
Crossref
Crossref
Vasudevaru Narayanan Bhattathiri. (2001) Relation of erythrocyte and iron indices to oral cancer growth. Radiotherapy and Oncology 59:2, pages 221-226.
Crossref
Crossref
Johannes Lutterbach & Roland Guttenberger. (2000) Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx. International Journal of Radiation Oncology*Biology*Physics 48:5, pages 1345-1350.
Crossref
Crossref
Parvesh Kumar. (2000) Tumor hypoxia and anemia: Impact on the efficacy of radiation therapy. Seminars in Hematology 37, pages 4-8.
Crossref
Crossref
C. Grau & J. Overgaard. 2000. Blood Perfusion and Microenvironment of Human Tumors. Blood Perfusion and Microenvironment of Human Tumors
101
112
.
Martin Busch, Harald Meden, Fattahi Meibodi, Eckhart D�hmke & Walther Kuhn. (1999) Long term results of definitive radiotherapy for cervical carcinoma using four applications of high dose rate afterloading. Cancer 86:8, pages 1520-1527.
Crossref
Crossref
Karin S Kapp, Georg F Stuecklschweiger, Daniel S Kapp, Johann Poschauko, Hellmuth Pickel, Manfred Lahousen & Arnulf Hackl. (1998) Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. International Journal of Radiation Oncology*Biology*Physics 42:3, pages 531-540.
Crossref
Crossref
Kodaira Takeshi, Karasawa Katsuyuki, Tanaka Yoshiaki, Shimizu Teppei, Matsuda Tadayoshi, Murakami Akira & Mizutani Katsumi. (1998) Definitive Radiotherapy Combined with High-Dose-Rate Brachytherapy for Stage III Carcinoma of the Uterine Cervix: Retrospective Analysis of Prognostic Factors Concerning Patient Characteristics and Treatment Parameters. International Journal of Radiation Oncology*Biology*Physics 41:2, pages 319-327.
Crossref
Crossref
L T Tan, B Jones, A Gee & R E Kingston. (1997) An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.. The British Journal of Radiology 70:840, pages 1259-1269.
Crossref
Crossref